Valuation: AstraZeneca PLC

Market Cap 26TCr 23TCr 21TCr 19TCr 36TCr 24,70000Cr 37TCr 2,55600Cr 99TCr 12,60900Cr 97TCr 95TCr 40,51800Cr P/E 2026 *
21.2x
P/E 2027 * 18.5x
Enterprise Value 28TCr 24TCr 23TCr 21TCr 39TCr 26,58700Cr 40TCr 2,75100Cr 1,06400Cr 13,57300Cr 1,04200Cr 1,01900Cr 43,61300Cr EV / Sales 2026 *
4.39x
EV / Sales 2027 * 4.02x
Free-Float
96.62%
Yield 2026 *
2.01%
Yield 2027 * 2.13%
1 day+1.23%
1 week+0.42%
Current month+4.86%
1 month+0.61%
3 months-10.74%
6 months-10.74%
Current year-8.98%
1 week 12,316
Extreme 12316
12,690
1 month 11,552
Extreme 11552
12,690
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,090.32
Extreme 8090.32
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Free

Chief Financial Officer

73 0.0000%
14/09/26 Buy

Chairman

2,500 0.0002%
14/09/26 Buy

Chief Executive Officer

60,000 0.0039%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+0.42%+14.57%+12.13% 26TCr
+0.13%+2.65%+65.61%+114.28% 1,05500Cr
+0.20%+0.46%+52.60%+69.24% 65TCr
-0.29%+0.14%+20.96%+70.93% 47TCr
-0.85%+0.98%+41.29%+44.38% 35TCr
+0.71%+4.08%+22.24%+29.51% 27TCr
+2.11%+7.51%+52.89%+55.37% 22TCr
+0.83%+0.55%+35.99%+101.70% 19TCr
0.00%-10.14%-29.94%-60.30% 17TCr
+0.92%+3.65%+21.48%-13.07% 16TCr
Average +0.50%+1.03%+29.77%+42.42% 38.02TCr
Weighted average by Cap. +0.30%+1.42%+40.67%+64.35%

Financials

2026 *2027 *
Net sales 6.32TCr 5.55TCr 5.23TCr 4.77TCr 8.93TCr 6,05300Cr 8.99TCr 63TCr 24TCr 3,09000Cr 24TCr 23TCr 9,92900Cr 6.7TCr 5.88TCr 5.55TCr 5.06TCr 9.48TCr 6,42100Cr 9.54TCr 66TCr 26TCr 3,27800Cr 25TCr 25TCr 10,53300Cr
Net income 1.2TCr 1.06TCr 997.57Cr 909.02Cr 1.7TCr 1,15400Cr 1.71TCr 12TCr 4.62TCr 59TCr 4.52TCr 4.42TCr 1,89300Cr 1.38TCr 1.21TCr 1.14TCr 1.04TCr 1.95TCr 1,32000Cr 1.96TCr 14TCr 5.28TCr 67TCr 5.17TCr 5.06TCr 2,16500Cr
Net Debt 1.97TCr 1.73TCr 1.63TCr 1.49TCr 2.78TCr 1,88700Cr 2.8TCr 20TCr 7.55TCr 96TCr 7.39TCr 7.23TCr 3,09600Cr 1.19TCr 1.05TCr 988.23Cr 900.51Cr 1.69TCr 1,14300Cr 1.7TCr 12TCr 4.57TCr 58TCr 4.48TCr 4.38TCr 1,87500Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
25/26/25 GBX 12,552.00 +1.23% 17,35,781
24/26/24 GBX 12,400.00 -0.24% 21,12,195
23/26/23 GBX 12,430.00 -1.91% 16,90,606
22/26/22 GBX 12,672.00 +0.89% 48,21,835
21/26/21 GBX 12,560.00 +0.48% 39,16,914
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
166.19USD
Average target price
211.41USD
Spread / Average Target
+27.21%

Quarterly revenue - Rate of surprise